BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 22342841)

  • 1. Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity.
    Babon JJ; Kershaw NJ; Murphy JM; Varghese LN; Laktyushin A; Young SN; Lucet IS; Norton RS; Nicola NA
    Immunity; 2012 Feb; 36(2):239-50. PubMed ID: 22342841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of IL-6 family cytokines by SOCS3.
    Babon JJ; Varghese LN; Nicola NA
    Semin Immunol; 2014 Feb; 26(1):13-9. PubMed ID: 24418198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition.
    Kershaw NJ; Murphy JM; Liau NP; Varghese LN; Laktyushin A; Whitlock EL; Lucet IS; Nicola NA; Babon JJ
    Nat Struct Mol Biol; 2013 Apr; 20(4):469-76. PubMed ID: 23454976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biology and mechanism of action of suppressor of cytokine signaling 3.
    Babon JJ; Nicola NA
    Growth Factors; 2012 Aug; 30(4):207-19. PubMed ID: 22574771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Janus kinases by SOCS proteins.
    Kershaw NJ; Murphy JM; Lucet IS; Nicola NA; Babon JJ
    Biochem Soc Trans; 2013 Aug; 41(4):1042-7. PubMed ID: 23863176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line.
    Ruscica M; Ricci C; Macchi C; Magni P; Cristofani R; Liu J; Corsini A; Ferri N
    J Biol Chem; 2016 Feb; 291(7):3508-19. PubMed ID: 26668321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling.
    Narazaki M; Fujimoto M; Matsumoto T; Morita Y; Saito H; Kajita T; Yoshizaki K; Naka T; Kishimoto T
    Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13130-4. PubMed ID: 9789053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of SOCS (Suppressor of Cytokine Signaling) SH2 Domains for Structural and Functional Studies.
    Liau NP; Laktyushin A; Babon JJ
    Methods Mol Biol; 2017; 1555():173-182. PubMed ID: 28092033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation.
    Boyle K; Zhang JG; Nicholson SE; Trounson E; Babon JJ; McManus EJ; Nicola NA; Robb L
    Cell Signal; 2009 Mar; 21(3):394-404. PubMed ID: 19056487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells.
    Barclay JL; Anderson ST; Waters MJ; Curlewis JD
    Mol Endocrinol; 2007 Oct; 21(10):2503-15. PubMed ID: 17609438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structure of SOCS3 reveals the basis of the extended SH2 domain function and identifies an unstructured insertion that regulates stability.
    Babon JJ; McManus EJ; Yao S; DeSouza DP; Mielke LA; Sprigg NS; Willson TA; Hilton DJ; Nicola NA; Baca M; Nicholson SE; Norton RS
    Mol Cell; 2006 Apr; 22(2):205-16. PubMed ID: 16630890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for phosphotyrosine recognition by suppressor of cytokine signaling-3.
    Bergamin E; Wu J; Hubbard SR
    Structure; 2006 Aug; 14(8):1285-92. PubMed ID: 16905102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor of Cytokine Signaling (SOCS) 5 utilises distinct domains for regulation of JAK1 and interaction with the adaptor protein Shc-1.
    Linossi EM; Chandrashekaran IR; Kolesnik TB; Murphy JM; Webb AI; Willson TA; Kedzierski L; Bullock AN; Babon JJ; Norton RS; Nicola NA; Nicholson SE
    PLoS One; 2013; 8(8):e70536. PubMed ID: 23990909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary structure assignment of mouse SOCS3 by NMR defines the domain boundaries and identifies an unstructured insertion in the SH2 domain.
    Babon JJ; Yao S; DeSouza DP; Harrison CF; Fabri LJ; Liepinsh E; Scrofani SD; Baca M; Norton RS
    FEBS J; 2005 Dec; 272(23):6120-30. PubMed ID: 16302975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpastatin counteracts pathological angiogenesis by inhibiting suppressor of cytokine signaling 3 degradation in vascular endothelial cells.
    Miyazaki T; Taketomi Y; Saito Y; Hosono T; Lei XF; Kim-Kaneyama JR; Arata S; Takahashi H; Murakami M; Miyazaki A
    Circ Res; 2015 Mar; 116(7):1170-81. PubMed ID: 25648699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
    Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
    Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
    Ortiz-Muñoz G; Martin-Ventura JL; Hernandez-Vargas P; Mallavia B; Lopez-Parra V; Lopez-Franco O; Muñoz-Garcia B; Fernandez-Vizarra P; Ortega L; Egido J; Gomez-Guerrero C
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):525-31. PubMed ID: 19164812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of Novel Cavin-1/Suppressor of Cytokine Signaling 3 (SOCS3) Interactions by Coimmunoprecipitation, Peptide Pull-Down, and Peptide Array Overlay Approaches.
    Williams JJL; Baillie GS; Palmer TM
    Methods Mol Biol; 2020; 2169():105-118. PubMed ID: 32548823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOCS3 and SOCS5 mRNA expressions may predict initial steroid response in nephrotic syndrome children.
    Ostalska-Nowicka D; Smiech M; Jaroniec M; Zaorska K; Zawierucha P; Szaflarski W; Malinska A; Nowicki M
    Folia Histochem Cytobiol; 2011; 49(4):719-28. PubMed ID: 22252769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo.
    Boyle K; Egan P; Rakar S; Willson TA; Wicks IP; Metcalf D; Hilton DJ; Nicola NA; Alexander WS; Roberts AW; Robb L
    Blood; 2007 Sep; 110(5):1466-74. PubMed ID: 17510322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.